<ul><li>Dassault Systèmes has made a strategic investment in Click Therapeutics, a company specializing in prescription digital therapeutics (PDTs) and software-enhanced (SE) drug therapies.</li><li>The investment aims to enhance patient engagement throughout the healthcare journey, from post-trial phases to commercialization, by creating a unified offering for digital and pharmaceutical clinical trials.</li><li>The collaboration will support the development and approval of PDTs and SE products, expand labels for existing therapeutics, and generate real-world evidence.</li><li>Dassault Systèmes' global presence and expertise, combined with Click Therapeutics' capabilities, will accelerate the integration of digital therapeutics into the broader healthcare ecosystem.</li></ul>

Dassault Systèmes Invests in Click Therapeutics to Advance Digital Therapeutics

Discover more